NDC 33342-176 – Pioglitazone and metformin hydrochloride

Metformin Hydrochloride 500 mg/1; Pioglitazone Hydrochloride 15 mg/1 · Tablet · Oral

Human Prescription Drug 1 recall

Product NDC33342-176

Product details

Brand name
Pioglitazone and metformin hydrochloride
Generic name
Pioglitazone and metformin hydrochloride
Labeler
Macleods Pharmaceuticals Limited
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA204802
Marketed since
November 6, 2015
Listing expires
December 31, 2027
Pharmacologic class
Biguanide; Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione

Active ingredients

Uses, dosage, side effects and warnings for Pioglitazone and metformin hydrochloride →

Package NDC codes (5)

Package NDCDescriptionSince
33342-176-0960 TABLET in 1 BOTTLE (33342-176-09)Nov 6, 2015
33342-176-11100 TABLET in 1 BOTTLE (33342-176-11)Nov 6, 2015
33342-176-1210 BLISTER PACK in 1 CARTON (33342-176-12) / 10 TABLET in 1 BLISTER PACKNov 6, 2015
33342-176-441000 TABLET in 1 BOTTLE (33342-176-44)Nov 6, 2015
33342-176-57180 TABLET in 1 BOTTLE (33342-176-57)Nov 6, 2015

Recalls mentioning this NDC

Other Pioglitazone and metformin hydrochloride products